In view of the established role of surface CRT as an “eat me” signal [39,40], we next investigated the phagocytosis of the treated tumor cells by BM-derived DCs, a condition that is required for mounting immune response against dying tumor cells [41]. This evidence concerns the gene CALR and neoplasm.